Search Results - "Andrea Marzi"

Refine Results
  1. 1

    Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses by Letko, Michael, Marzi, Andrea, Munster, Vincent

    Published in Nature microbiology (01-04-2020)
    “…Over the past 20 years, several coronaviruses have crossed the species barrier into humans, causing outbreaks of severe, and often fatal, respiratory illness…”
    Get full text
    Journal Article
  2. 2

    Marburg virus pathogenesis - differences and similarities in humans and animal models by Shifflett, Kyle, Marzi, Andrea

    Published in Virology journal (30-12-2019)
    “…Marburg virus (MARV) is a highly pathogenic virus associated with severe disease and mortality rates as high as 90%. Outbreaks of MARV are sporadic, deadly,…”
    Get full text
    Journal Article
  3. 3

    Ebola virus disease sequelae and viral persistence in animal models: Implications for the future by Durant, Olivia, Marzi, Andrea

    Published in PLoS pathogens (01-03-2024)
    “…Ebola virus disease (EVD), caused by infection with Ebola virus, results in severe, acute illness with a high mortality rate. As the incidence of outbreaks of…”
    Get full text
    Journal Article
  4. 4

    Ebola: Lessons on Vaccine Development by Feldmann, Heinz, Feldmann, Friederike, Marzi, Andrea

    Published in Annual review of microbiology (08-09-2018)
    “…The West African Ebola virus (EBOV) epidemic has fast-tracked countermeasures for this rare, emerging zoonotic pathogen. Until 2013-2014, most EBOV vaccine…”
    Get full text
    Journal Article
  5. 5

    The Ebola virus soluble glycoprotein contributes to viral pathogenesis by activating the MAP kinase signaling pathway by Furuyama, Wakako, Shifflett, Kyle, Feldmann, Heinz, Marzi, Andrea

    Published in PLoS pathogens (16-09-2021)
    “…Ebola virus (EBOV) expresses three different glycoproteins (GPs) from its GP gene. The primary product, soluble GP (sGP), is secreted in abundance during…”
    Get full text
    Journal Article
  6. 6

    Ebola Virus: Pathogenesis and Countermeasure Development by Furuyama, Wakako, Marzi, Andrea

    Published in Annual review of virology (29-09-2019)
    “…Since its discovery in 1976, Ebola virus (EBOV) has caused numerous outbreaks of fatal hemorrhagic disease in Africa. The biggest outbreak on record is the…”
    Get full text
    Journal Article
  7. 7

    Vesicular stomatitis virus-based vaccines against Lassa and Ebola viruses by Marzi, Andrea, Feldmann, Friederike, Geisbert, Thomas W, Feldmann, Heinz, Safronetz, David

    Published in Emerging infectious diseases (01-02-2015)
    “…We demonstrated that previous vaccination with a vesicular stomatitis virus (VSV)-based Lassa virus vaccine does not alter protective efficacy of subsequent…”
    Get full text
    Journal Article
  8. 8
  9. 9

    The vesicular stomatitis virus-based Ebola virus vaccine: From concept to clinical trials by Suder, Ellen, Furuyama, Wakako, Feldmann, Heinz, Marzi, Andrea, de Wit, Emmie

    Published in Human vaccines & immunotherapeutics (02-09-2018)
    “…The devastating Ebola virus (EBOV) epidemic in West Africa in 2013-2016 accelerated the progress of several vaccines and antivirals through clinical trials,…”
    Get full text
    Journal Article
  10. 10

    Filovirus vaccines as a response paradigm for emerging infectious diseases by Marzi, Andrea, Feldmann, Heinz

    Published in npj vaccines (11-10-2024)
    “…Nowadays, filovirus vaccine development may be seen as a paradigm for our response capabilities to emerging and re-emerging infectious diseases. Specifically,…”
    Get full text
    Journal Article
  11. 11

    A VSV-based Zika virus vaccine protects mice from lethal challenge by Emanuel, Jackson, Callison, Julie, Dowd, Kimberly A., Pierson, Theodore C., Feldmann, Heinz, Marzi, Andrea

    Published in Scientific reports (23-07-2018)
    “…Infection with Zika virus (ZIKV) is commonly mild in humans but has been associated with alarming negative health outcomes including Guillain-Barré syndrome in…”
    Get full text
    Journal Article
  12. 12

    A complement component C1q-mediated mechanism of antibody-dependent enhancement of Ebola virus infection by Furuyama, Wakako, Nanbo, Asuka, Maruyama, Junki, Marzi, Andrea, Takada, Ayato

    Published in PLoS neglected tropical diseases (01-09-2020)
    “…Besides the common Fc receptor (FcR)-mediated mechanism of antibody-dependent enhancement (ADE), Ebola virus (EBOV) is known to utilize the complement…”
    Get full text
    Journal Article
  13. 13

    A fatty acid-ordered plasma membrane environment is critical for Ebola virus matrix protein assembly and budding by Amiar, Souad, Johnson, Kristen A., Husby, Monica L., Marzi, Andrea, Stahelin, Robert V.

    Published in Journal of lipid research (01-11-2024)
    “…Plasma membrane (PM) domains and order phases have been shown to play a key role in the assembly, release, and entry of several lipid-enveloped viruses. In the…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Lack of protection against ebola virus from chloroquine in mice and hamsters by Falzarano, Darryl, Safronetz, David, Prescott, Joseph, Marzi, Andrea, Feldmann, Friederike, Feldmann, Heinz

    Published in Emerging infectious diseases (01-06-2015)
    “…The antimalarial drug chloroquine has been suggested as a treatment for Ebola virus infection. Chloroquine inhibited virus replication in vitro, but only at…”
    Get full text
    Journal Article
  16. 16

    Delayed Disease Progression in Cynomolgus Macaques Infected with Ebola Virus Makona Strain by Marzi, Andrea, Feldmann, Friederike, Hanley, Patrick W, Scott, Dana P, Günther, Stephan, Feldmann, Heinz

    Published in Emerging infectious diseases (01-10-2015)
    “…In late 2013, the largest documented outbreak of Ebola hemorrhagic fever started in Guinea and has since spread to neighboring countries, resulting in almost…”
    Get full text
    Journal Article
  17. 17

    An Ebola whole-virus vaccine is protective in nonhuman primates by Marzi, Andrea, Halfmann, Peter, Hill-Batorski, Lindsay, Feldmann, Friederike, Shupert, W. Lesley, Neumann, Gabriele, Feldmann, Heinz, Kawaoka, Yoshihiro

    “…Zaire ebolavirus is the causative agent of the current outbreak of hemorrhagic fever disease in West Africa. Previously, we showed that a whole Ebola virus…”
    Get full text
    Journal Article
  18. 18

    Antiviral Innate Responses Induced by VSV-EBOV Vaccination Contribute to Rapid Protection by Menicucci, Andrea R, Jankeel, Allen, Feldmann, Heinz, Marzi, Andrea, Messaoudi, Ilhem

    Published in mBio (28-05-2019)
    “…Ebola virus (EBOV) is a single-stranded RNA virus that causes Ebola virus disease (EVD), characterized by excessive inflammation, lymphocyte apoptosis,…”
    Get full text
    Journal Article
  19. 19

    Monoclonal Antibody Cocktail Protects Hamsters From Lethal Marburg Virus Infection by Marzi, Andrea, Haddock, Elaine, Kajihara, Masahiro, Feldmann, Heinz, Takada, Ayato

    Published in The Journal of infectious diseases (22-11-2018)
    “…Marburg virus (MARV), family Filoviridae, causes Marburg hemorrhagic fever (MHF) in humans and nonhuman primates with case fatality rates of up to 90%. There…”
    Get full text
    Journal Article
  20. 20

    Development of an Enzyme-Linked Immunosorbent Assay to Determine the Expression Dynamics of Ebola Virus Soluble Glycoprotein during Infection by Furuyama, Wakako, Marzi, Andrea

    Published in Microorganisms (Basel) (06-10-2020)
    “…Ebola virus (EBOV) is a highly pathogenic virus with human case fatality rates of up to 90%. EBOV uses transcriptional editing to express three different…”
    Get full text
    Journal Article